DiaMedica Therapeutics, Inc. (DMAC)
8.50
+0.15
(+1.80%)
USD |
NASDAQ |
Dec 24, 12:59
8.50
0.00 (0.00%)
After-Hours: 13:59
DiaMedica Therapeutics SG&A Expense (TTM): 9.218M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 32.68M |
| Avantor, Inc. | 1.574B |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |
| Theriva Biologics, Inc. | 16.21M |